Addex Rises Most in a Year After Drug Works in Study (Update2) – Bloomberg
2009 November 17
November 16 (Bloomberg) – Addex Pharmaceuticals Ltd, a company most of the Zurich trading after the company announced its most advanced compound to help with the heartburn condition of the medium-term phase of the study patients a year. Gastroesophageal reflux disease …
Read More






